대장내시경 전 처치 약제 Solin® 투여 후 발생한 고인산혈증 및 급성신부전 1예
A case of hyperphosphatemia and acute renal failure following the administration of solin® (oral sodium phosphate)
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Solin® (oral sodium phosphate) is a commonly used osmotic laxative solution that has replaced polyethylene glycol in bowel preparation for colonoscopy as it has equal or greater efficacy and patient compliance. However, its use has been associated with several cases of acute renal failure and electrolyte imbalance, especially hyperphosphatemia and hypocalcemia. Those at higher risk of complications are patients who are older and have intestinal obstruction, inflammatory bowel disease, renal failure, or congestive heart failure. We report the case of a 61-year-old woman presenting with paresthesia in both hands after using Solin® for bowel preparation for colonoscopy. The patient had hypocalcemia and hyperphosphatemia combined with acute renal failure. She recovered from the renal failure and electrolyte imbalance with intravenous hydration and treatment with phosphate-binding agents. (Korean J Med 75:689-693, 2008)
Abstract
Solin® (oral sodium phosphate) is a commonly used osmotic laxative solution that has replaced polyethylene glycol in bowel preparation for colonoscopy as it has equal or greater efficacy and patient compliance. However, its use has been associated with several cases of acute renal failure and electrolyte imbalance, especially hyperphosphatemia and hypocalcemia. Those at higher risk of complications are patients who are older and have intestinal obstruction, inflammatory bowel disease, renal failure, or congestive heart failure. We report the case of a 61-year-old woman presenting with paresthesia in both hands after using Solin® for bowel preparation for colonoscopy. The patient had hypocalcemia and hyperphosphatemia combined with acute renal failure. She recovered from the renal failure and electrolyte imbalance with intravenous hydration and treatment with phosphate-binding agents. (Korean J Med 75:689-693, 2008)
참고문헌 (20)
- 윤성현, "선택 대장절제술에서 Polyethylene Glycol과 Sodium Phosphate의 장세정 효과에 대한 전향적 비교 연구", Annals of Coloproctolgy, 20(1), pp.27~31 (2004), 대한대장항문학회
- Hsu CW, "Meta-analysis and cost comparison of polyethylene glycol lavage versus sodium phosphate for colonoscopy preparation", Gastrointest Endosc, 48, pp.276~282 (1998)
- Markowitz GS, "Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure", J Am Soc Nephrol, 16, pp.3389~3396+ (2005)
- 김일순, "Sodium Phosphate에 의한 급성 신부전 1예", Kidney Research and Clinical Practice, 20(6), pp.1098~1101 (2001), 대한신장학회
- 전연주, "경구 Polyethylene Glycol (Colyte)을 복용한 후 발생한 급성신부전 1예", Clinical Endoscopy, 34(3), pp.161~163 (2007), 대한소화기내시경학회
- Nelson BD, "Technology status evaluation report: colonoscopy preparations", Gastrointest Endosc, 54, pp.829~832 (2001)
- Vanner SJ, "A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (Golytely) in the preparation of patients for colonoscopy", Am J Gastroenterol, 85, pp.422~427 (1990)
- Cohen SM, "Prospective, randomized, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods", Dis Colon Rectum, 37, pp.689~696 (1994)
- Fine A, "Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: 2 cases and a review of the literature", Am J Kidney Dis, 29, pp.103~105 (1997)
- Korzets A, "Life-threatening hyperphosphatemia and hypocalcemic tetay following the use of fleet enemas", J Am Geriatr Soc, 40, pp.620~621 (1992)
- Shaoul R, "Symptoms of hyperphosphatemia, hypocalcemia, and hypomagnesemia in an adolescent after the oral administration of sodium phosphate in preparation for a colonoscopy", Gastrointest Endosc, 53, pp.650~652 (2001)
- Hookey LC, "Recognizing the clinical contraindications to the use of oral sodium phosphate for colon cleansing: a case study", Can J Gastroenterol, 18, pp.455~458 (2004)
- Center for Drug Evaluation and Research, U.S, "Food and Drug Administration. Oral Sodium Phosphate (OSP) products for bowel cleansing" (2006), U.S. Govt. Printing Office
- Boles JM, "Acute renal failure acused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia", Cancer, 53, pp.2425~2429 (1984)
- Herbert LA, "Studies of the mechanism by which phosphate infusion lowers serum calcium concentration", J Clin Invest, 45, pp.1886~1894 (1966)
- Desmeules S, "Acute phosphate nephropathy and renal failure", N Engl J Med, 349, pp.1006~1007 (2003)
- Zager R, "Hyperphosphatemia: a factor that provokes severe experimental acute renal failure", J Lab Clin Med, 100, pp.230~239 (1982)
- McConnell TH, "Fatal hypocalcemia from phosphate absorption from laxative prepatation", JAMA, 216, pp.147~148 (1971)
- Orias M, "Extreme hyperphosphatemia and acute renal failure after a phosphoruscontaining bowel regimen", Am J Nephrol, 19, pp.60~63 (1999)
- Gonlusen G, "Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing", Arch Pathol Lab Med, 130, pp.101~106 (2006)